Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$1.86 - $6.98 $98,394 - $369,242
52,900 Added 413.28%
65,700 $448,000
Q1 2024

May 07, 2024

BUY
$1.5 - $3.41 $19,200 - $43,648
12,800 New
12,800 $32,000
Q2 2023

Aug 11, 2023

BUY
$7.35 - $13.21 $82,320 - $147,952
11,200 Added 74.67%
26,200 $192,000
Q1 2023

May 16, 2023

BUY
$7.79 - $16.29 $8,569 - $17,919
1,100 Added 7.91%
15,000 $155,000
Q4 2022

Feb 14, 2023

BUY
$11.0 - $21.45 $152,900 - $298,155
13,900 New
13,900 $164,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $422M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.